Click here to narrow your options by answering a few questions.

Prostate Cancer
Treatment Guide™

Prostate Cancer Treatment News

 

Brachytherapy

Chemotherapy

Cryotherapy & Cryosurgery

Hormone
Therapy

Radiation
Therapy

Prostatectomy

Robotic Prostatectomy

Watchful
Waiting

Complementary
and
Alternative Medicine

High Intensity
Focused
Ultrasound (HIFU)

Emerging Technologies

 

Research could help improve early diagnosis of prostate cancer
Prostate cancer patients could get better diagnosis and treatment for the disease in the future thanks to a successful research project at the University of Essex.Currently, is it difficult to distinguish between benign and aggressive malignant tumours, meaning some prostate cancer patients are unnecessarily "over-treated" which can lead to needless distress and anxiety.

Enzalutamide for metastatic prostate cancer: IQWiG assessed data subsequently submitted by the manufacturer
Now indication and hint of major added benefit for patients with metastatic prostate cancerEnzalutamide (trade name: Xtandi) has been approved since June 2013 for men with metastatic prostate cancer in whom the commonly used hormone blockade is no longer effective and who have already been treated with the cytostatic drug docetaxel.

Increased risk of prostate cancer in some men taking selenium and vitamin E supplements
A multi-center study led by Fred Hutchinson Cancer Research Center has found that high-dose supplementation with both the trace element selenium and vitamin E increase the risk of high-grade prostate cancer. But importantly, this risk depends upon a man's selenium status before taking the supplements.

Identifying men with advanced prostate cancer through genetic screening
Screening men with a family history of prostate cancer for a range of gene mutations can identify those who are at high risk of aggressive forms of the disease and in need of lifelong monitoring, a new study has shown.

Selenium and vitamin E supplements 'increase prostate cancer risk'
A new study recently published in the Journal of the National Cancer Institute suggests that taking high doses of selenium and vitamin E supplements may increase the risk of prostate cancer, depending on a man's selenium levels prior to taking the supplements.The research team, including first author Dr.

Advanced prostate cancer risk could be identified by genetic screening
New research from the Institute of Cancer Research in the UK suggests that screening men with a family history of prostate cancer for certain gene mutations could identify those who are at increased risk of aggressive forms of the disease and need lifelong monitoring.

Genetic screening could identify risk of advanced prostate cancer
New research from the Institute of Cancer Research in the UK suggests that screening men with a family history of prostate cancer for certain gene mutations could identify those who are at increased risk of aggressive forms of the disease and need lifelong monitoring.

Data shows Prolaris test predicts metastases in prostate cancer from biopsies
Myriad Genetics, Inc. has announced it has published data in the Journal of Urology demonstrating that its Prolaris test accurately predicted, based on biopsy specimens, which men would develop biochemical recurrence (BCR) or metastatic disease following radical prostate surgery.

Proton therapy for prostate cancer results in long-term patient survival and excellent quality of life
Five years after having proton therapy for early- and intermediate-risk prostate cancer, 99 percent of men are living cancer-free and with excellent quality of life, according to a University of Florida Proton Therapy Institute study. Three-quarters of those with high-risk prostate cancer are also disease-free.

Prostate cancer advance could improve treatment options
Researchers at the University of East Anglia have made an important advance in understanding genetic changes associated with terminal prostate cancer.Findings published today in the British Journal of Cancer, and funded by the Association for International Cancer Research (AICR), show how a genetic mutation in untreated patients is linked to aggressive cancer later in life.

Previous Prostate Cancer News More Prostate Cancer News
 
 

 
 
 
 

Coping with Prostate Cancer      Are You at Risk for Prostate Cancer?      Prostate Cancer News     Glossary

 Home     Contact Us     Disclaimer    Privacy Policy     Site Map